Blog
Posted on 23.11.2018
Can the EU directive on public procurement encourage value-based procurement in healthcare?
When the new EU Directive on public procurement was finalised in 2014, replacing the previous framework, it was hailed by the European Parliament as a tool for ensuring better quality of supplies and services and value for money. The European Parliament was also keen to emphasise how the Directive was designed to encourage innovation, improve SMEs’ access to public sector markets and to integrate environmental and social considerations into procurement policy.
Posted on 23.11.2018
Value-Based Procurement: The New Healthcare Imperative
Despite heroic efforts to control healthcare costs, Canada is still among the countries with the highest healthcare expenditures. In 2013, Canada spent 10.2% of its GDP on healthcare, which was above the average for its peer OECD countries. Yet, the quality of healthcare services does not always match this level of investment. There are still great variations in healthcare quality across the country and, most importantly, Canada’s performance is weak on key indicators when compared with its peer countries. For example, as shown in the Conference Board of Canada’s latest How Canada Performs report card, Canada obtained “C”s for mortality due to cancer, mortality due to diabetes, mortality due to musculoskeletal diseases, and infant mortality. Canada’s health performance has dropped to 10th place from a much more enviable 5th place in the 1990s out of 17 peer countries.
Posted on 23.11.2018
Shift to value-based procurement must come from the top
Procurement officials can play an important role in delivering better value for hospitals and healthcare systems. They can do this by doing what is most economically advantageous while simultaneously fostering innovations that benefits patients. However, they need a clear signal from management and policymakers encouraging them to think strategically.
Posted on 23.11.2018
Value-Based Procurement: can the industry just “wait and see?”
Earlier this year you could read about a new partnership between MedTech Europe and BCG where the aim was to define a framework for Most Economically Advantageous Tendering (MEAT) for the medical technology industry. Since then a few months have passed by, and I was really happy to see the first results of this partnership during the gathering of procurement officials in Lisbon end of September.
Posted on 13.11.2018
Artificial intelligence: The next revolution in healthcare?
At the turn of the century, healthcare companies were at the zenith of an ‘innovate-manufacture-sell’ business model. It was a good time to be in medical technology. European and American companies were leading the way. While for many companies, this model is still alive and well, those at the forefront of the AI and robotics curve know they are part of a new revolution in healthcare.
Posted on 13.11.2018
Health data can transform our lives – but must be used wisely
There is considerable hype around the potential of big data to change healthcare. Much of this is justified: large datasets and increased computing power are combining to make healthcare more personalised, more precise and more predictable.
